Literature DB >> 9682526

Effects of an expanding-spaced vs massed exposure schedule on fear reduction and return of fear.

M K Rowe1, M G Craske.   

Abstract

The current investigation assessed the relative benefits of a massed vs an expanding-spaced exposure schedule. The study was a 2 (distribution of sessions) x 3 (assessment occasion) design, in which two spider-fearful groups (N = 31) were compared across three different occasions: pre-training, post-training, and follow-up. Four exposure trials were conducted within the same day for participants in the massed exposure (ME) group, whereas sessions were distributed over the course of 1 week (inter-trial intervals doubled between sessions) for the expanding-spaced exposure (ESE) group. As predicted, although the ME group demonstrated significantly more habituation than the ESE group across exposure trials, they also showed a clear return of fear (ROF) in response to the training spider at a 1-month follow-up assessment, whereas the ESE group showed no increase in fear. Additionally, the ME group showed ROF in response to novel spiders post-training and at the 1-month follow-up, whereas ESE participants did not. These findings offer support for the beneficial effects of an expanding-spaced schedule and challenge the reliance on indices of fear activation and habituation as accurate signals of the permanence of fear reduction.

Entities:  

Mesh:

Year:  1998        PMID: 9682526     DOI: 10.1016/s0005-7967(97)10016-x

Source DB:  PubMed          Journal:  Behav Res Ther        ISSN: 0005-7967


  24 in total

1.  Operant conditioning in Lymnaea: evidence for intermediate- and long-term memory.

Authors:  K Lukowiak; N Adatia; D Krygier; N Syed
Journal:  Learn Mem       Date:  2000 May-Jun       Impact factor: 2.460

2.  Expanding the intertrial interval during extinction: response cessation and recovery.

Authors:  Alyssa J Orinstein; Gonzalo P Urcelay; Ralph R Miller
Journal:  Behav Ther       Date:  2009-06-01

Review 3.  The assessment and treatment of specific phobias: a review.

Authors:  Daniel F Grös; Martin M Antony
Journal:  Curr Psychiatry Rep       Date:  2006-08       Impact factor: 5.285

4.  Development of a water-escape motivated version of the Stone T-maze for mice.

Authors:  P J Pistell; D K Ingram
Journal:  Neuroscience       Date:  2009-12-22       Impact factor: 3.590

5.  Optimizing exposure-based CBT for anxiety disorders via enhanced extinction: Design and methods of a multicentre randomized clinical trial.

Authors:  Ingmar Heinig; Andre Pittig; Jan Richter; Katrin Hummel; Isabel Alt; Kristina Dickhöver; Jennifer Gamer; Maike Hollandt; Katja Koelkebeck; Anne Maenz; Sophia Tennie; Christina Totzeck; Yunbo Yang; Volker Arolt; Jürgen Deckert; Katharina Domschke; Thomas Fydrich; Alfons Hamm; Jürgen Hoyer; Tilo Kircher; Ulrike Lueken; Jürgen Margraf; Peter Neudeck; Paul Pauli; Winfried Rief; Silvia Schneider; Benjamin Straube; Andreas Ströhle; Hans-Ulrich Wittchen
Journal:  Int J Methods Psychiatr Res       Date:  2017-03-21       Impact factor: 4.035

Review 6.  Animal models of fear relapse.

Authors:  Travis D Goode; Stephen Maren
Journal:  ILAR J       Date:  2014

Review 7.  The fear-avoidance model of musculoskeletal pain: current state of scientific evidence.

Authors:  Maaike Leeuw; Mariëlle E J B Goossens; Steven J Linton; Geert Crombez; Katja Boersma; Johan W S Vlaeyen
Journal:  J Behav Med       Date:  2006-12-20

Review 8.  Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders.

Authors:  N Singewald; C Schmuckermair; N Whittle; A Holmes; K J Ressler
Journal:  Pharmacol Ther       Date:  2014-12-27       Impact factor: 12.310

9.  Does change in distress matter? Mechanisms of change in prolonged exposure for PTSD.

Authors:  Ellen J Bluett; Lori A Zoellner; Norah C Feeny
Journal:  J Behav Ther Exp Psychiatry       Date:  2013-09-13

10.  Extinction-reconsolidation boundaries: key to persistent attenuation of fear memories.

Authors:  Marie-H Monfils; Kiriana K Cowansage; Eric Klann; Joseph E LeDoux
Journal:  Science       Date:  2009-04-02       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.